Induction of salivary gland epithelial cell injury in Sjogren's syndrome: in vitro assessment of T cell-derived cytokines and Fas protein expression.

Sjogren's syndrome (SS) is an exocrinopathy characterized by T cell infiltrates, salivary gland epithelial cell (SGEC) apoptosis and high Fas and FasL expression. To address the participation of T cell-derived cytokines and of Fas apoptotic pathway in SS glandular lesions, we utilized non-neoplastic SGEC lines established from SS patients and controls. Possibly attesting to their intrinsic activation, cell lines derived from SS patients displayed significantly higher constitutive Fas and FasL than controls. Surface co-expression of Fas and FasL was not associated with spontaneous fratricide apoptosis. SGEC were resistant to anti-Fas-mediated apoptosis (possibly owing to the constitutive expression of anti-apoptotic proteins cFLIP and Bcl-2), but became sensitive after protein or RNA synthesis inhibition. IFN-gamma and TNF-alpha were able to upregulate surface Fas and FasL, whereas IL-1beta downregulated surface FasL. IFN-gamma (but not several other cytokines) reduced the survival of SGEC in a dose- and time-dependent manner and induced Fas/FasL-mediated apoptosis, directly and via anoikia. Dexamethasone inhibited the upregulation of Fas and FasL by IFN-gamma and the induction of SGEC apoptosis and detachment by anti-Fas mAb or IFN-gamma. Our findings indicate the injurious role of IFN-gamma for the salivary epithelia of SS patients through the induction of Fas-mediated apoptosis and anoikia.

[1]  E. Kapsogeorgou,et al.  Activation of epithelial and myoepithelial cells in the salivary glands of patients with Sjögren's syndrome: high expression of intercellular adhesion molecule‐1 (ICAM.1) in biopsy specimens and cultured cells , 2001, Clinical and experimental immunology.

[2]  Chulhee Choi,et al.  Differential Regulation and Function of Fas Expression on Glial Cells1 , 2000, The Journal of Immunology.

[3]  H. Moutsopoulos,et al.  Sjögren's syndrome: autoimmune epithelitis. , 1994, Bailliere's best practice & research. Clinical rheumatology.

[4]  A. Tzioufas,et al.  Sjögren's syndrome. Autoimmune epithelitis. , 2000, Advances in experimental medicine and biology.

[5]  M. Konopleva,et al.  Apoptosis. Molecules and mechanisms. , 1999, Advances in experimental medicine and biology.

[6]  C. Riccardi,et al.  Glucocorticoid hormone-induced modulation of gene expression and regulation of T-cell death: role of GITR and GILZ, two dexamethasone-induced genes , 1999, Cell Death and Differentiation.

[7]  J. Bonnefoy,et al.  Annexin V used for measuring apoptosis in the early events of cellular cytotoxicity. , 1999, Cytometry.

[8]  K. Tsubota,et al.  Preferential Localization of CD8+ αEβ7+ T Cells Around Acinar Epithelial Cells with Apoptosis in Patients with Sjögren’s Syndrome , 1999, The Journal of Immunology.

[9]  K. Asadullah,et al.  Crosstalk between keratinocytes and T lymphocytes via Fas/Fas ligand interaction: modulation by cytokines. , 1999, Journal of immunology.

[10]  M. Humphreys-Beher,et al.  The role of apoptosis in the initiation of the autoimmune response in Sjögren's syndrome , 1999, Clinical and experimental immunology.

[11]  Y. Ahn,et al.  Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-alpha, or IFN-gamma. , 1999, Journal of immunology.

[12]  H. Moutsopoulos,et al.  Expression of B7 costimulatory molecules by salivary gland epithelial cells in patients with Sjögren's syndrome. , 1999, Arthritis and rheumatism.

[13]  F. Shanahan,et al.  The Fas counterattack: cancer as a site of immune privilege. , 1999, Immunology today.

[14]  R. Schlapbach,et al.  TNF‐α and IFN‐γ render microglia sensitive to Fas ligand‐induced apoptosis by induction of Fas expression and down‐regulation of Bcl‐2 and Bcl‐xL , 1998 .

[15]  Theocharis,et al.  Modes of epithelial cell death and repair in Sjögren's syndrome (SS) , 1998, Clinical and experimental immunology.

[16]  T. Sumida,et al.  Glandular and extraglandular expression of the Fas-Fas ligand and apoptosis in patients with Sjögren's syndrome. , 1998, Clinical and experimental rheumatology.

[17]  P. Fox,et al.  Fas and Fas-mediated effects on a human salivary cell line in vitro: a model for immune-mediated exocrine damage in Sjögren's syndrome , 1998, Cell Death and Differentiation.

[18]  R. Maria,et al.  Fas-FasL interactions: a common pathogenetic mechanism in organ-specific autoimmunity. , 1998, Immunology today.

[19]  T. Ochi,et al.  Membrane Fas Ligand Kills Human Peripheral Blood T Lymphocytes, and Soluble Fas Ligand Blocks the Killing , 1997, The Journal of experimental medicine.

[20]  C. Riccardi,et al.  A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death. , 1997, Immunity.

[21]  G. Rosen,et al.  Dexamethasone inhibits lung epithelial cell apoptosis induced by IFN-γ and Fas. , 1997, American journal of physiology. Lung cellular and molecular physiology.

[22]  P. Walker,et al.  Role of Fas ligand (CD95L) in immune escape: the tumor cell strikes back. , 1997, Journal of immunology.

[23]  J. Polak,et al.  Role of nitric oxide in Sjögren's syndrome. , 1997, Arthritis and rheumatism.

[24]  M. Todaro,et al.  Potential Involvement of Fas and Its Ligand in the Pathogenesis of Hashimoto's Thyroiditis , 1997, Science.

[25]  U. Boehm,et al.  Cellular responses to interferon-gamma. , 1997, Annual review of immunology.

[26]  N. Ogawa,et al.  Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren's syndrome. , 1997, Arthritis and rheumatism.

[27]  K. Koretz,et al.  Early detachment of colon carcinoma cells during CD95(APO-1/Fas)- mediated apoptosis. I. De-adhesion from hyaluronate by shedding of CD44 , 1996, The Journal of cell biology.

[28]  F. Ramsdell,et al.  Fas and FasL in the homeostatic regulation of immune responses. , 1995, Immunology today.

[29]  D. Green,et al.  Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege , 1995, Science.

[30]  D. Green,et al.  Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl , 1995, The Journal of experimental medicine.

[31]  M. Weller,et al.  CD95 (Fas/APO-1) antibody-mediated apoptosis of human retinal pigment epithelial cells. , 1995, Biochemical and biophysical research communications.

[32]  S. Nagata,et al.  The Fas death factor , 1995, Science.

[33]  S. Nagata,et al.  Fas and Fas ligand: lpr and gld mutations. , 1995, Immunology today.

[34]  S. Yonehara,et al.  Involvement of apoptosis antigen Fas in clonal deletion of human thymocytes. , 1994, International immunology.

[35]  S. Nagata,et al.  Fas-mediated apoptosis in primary cultured mouse hepatocytes. , 1994, Experimental cell research.

[36]  B. Baum,et al.  Effect of tumor necrosis factor‐α and interferon‐γ on the growth of a human salivary gland cell line , 1994, Journal of cellular physiology.

[37]  J. Abrams,et al.  Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome. , 1994, Journal of immunology.

[38]  S. Ju,et al.  Participation of target Fas protein in apoptosis pathway induced by CD4+ Th1 and CD8+ cytotoxic T cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[39]  S. Frisch,et al.  Disruption of epithelial cell-matrix interactions induces apoptosis , 1994, The Journal of cell biology.

[40]  D. Isenberg,et al.  Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. , 1993, Arthritis and rheumatism.

[41]  K. Bendtzen,et al.  Cytokine expression in labial salivary glands from patients with primary Sjögren's syndrome. , 1992, Autoimmunity.

[42]  M. Merćep,et al.  Programmed T lymphocyte death. Cell activation- and steroid-induced pathways are mutually antagonistic. , 1990, Journal of immunology.

[43]  A. Drosos,et al.  Labial salivary gland immunopathology in Sjögren's syndrome. , 1986, Scandinavian journal of rheumatology. Supplement.

[44]  J. Cohen,et al.  Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. , 1984, Journal of immunology.